| Aug 1 |
Biogen Q2 Earnings: Beats Consensus, Lifts 2024 Profit Forecast As New Drug Launches Expected To Offset Decline In Multiple Sclerosis Med Sales
|
| Aug 1 |
Biogen Stock Slips As Alzheimer's Drug Looks Abroad For Quarterly Beat
|
| Aug 1 |
Biogen Lifts Earnings Guidance After Revenue Beats Forecasts
|
| Aug 1 |
Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
| Aug 1 |
Biogen posts Q2 beat as sales from Alzheimer’s drug pick up
|
| Aug 1 |
Biogen Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 1 |
Biogen Inc. (BIIB) Q2 Earnings and Revenues Top Estimates
|
| Aug 1 |
Meta Platforms, Ferrari, ConocoPhillips rise premarket; Arm, Moderna fall
|
| Aug 1 |
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
|
| Aug 1 |
Biogen Non-GAAP EPS of $4.02 misses by $0.01, revenue of $2.46B beats by $70M
|
